Binge-Eating Disorders (BED) Market was valued at USD 540 million in 2024 and is projected to reach USD 920 million by 2034,

Market Overview
The Binge-Eating Disorders (BED) Market was valued at USD 540 million in 2024 and is projected to reach USD 920 million by 2034, growing at a CAGR of 5.5% during the forecast period.

BED is the most common eating disorder globally, characterized by recurrent episodes of uncontrolled eating without compensatory behaviors. Rising global obesity rates, increased stress levels, growing awareness of mental health disorders, and enhanced psychiatric diagnostic capabilities are major contributors to market growth.

Demand for pharmacological treatments, behavioral therapies, digital mental health platforms, and multidisciplinary care programs continues to increase as both healthcare providers and patients recognize BED as a serious, treatable medical condition.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71896

Market Dynamics
Drivers
• Rising prevalence of obesity, metabolic disorders, and stress-induced eating behaviors.
• Increasing awareness and acceptance of mental health treatments, reducing stigma.
• Growing use of cognitive behavioral therapy (CBT), interpersonal therapy (IPT), and other evidence-based psychotherapies.
• Availability of FDA-approved medications for BED, such as lisdexamfetamine.
• Expansion of digital mental health platforms offering remote therapy and monitoring.

Restraints
• Underdiagnosis due to stigma, lack of awareness, and overlap with obesity.
• Limited availability of specialized eating disorder treatment centers in many regions.
• High cost of long-term psychotherapy, especially without insurance support.
• Side effects and safety concerns associated with stimulant medications used for BED.

Opportunities
• Development of next-generation pharmacotherapies targeting dopamine, serotonin, and impulse-control pathways.
• Integration of AI-based monitoring tools to track binge patterns and triggers.
• Expansion of digital therapy programs that increase accessibility and affordability.
• Collaboration between obesity and mental health programs for holistic treatment models.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/71896/binge-eating-disorders-market

Market Growth Outlook (2024-2034)
The BED Market will grow from USD 540 million in 2024 to USD 920 million in 2034, supported by rising demand for mental health services, improved diagnostic rates, and growing acceptance of multidisciplinary treatment. Digital behavioral health is expected to be a major growth driver over the next decade.

Segmentation Analysis
By Treatment Type
Pharmacotherapy, including lisdexamfetamine and off-label antidepressants (SSRIs/SNRIs), plays a growing role in symptom reduction.
Psychotherapy-especially cognitive behavioral therapy (CBT), interpersonal therapy (IPT), and dialectical behavior therapy (DBT)-remains the first-line treatment for most patients.

Nutritional counseling and lifestyle interventions support long-term recovery and weight management.
Digital mental health programs, mobile CBT apps, and virtual therapy sessions are rapidly expanding access to treatment.

By Patient Type
Adults represent the largest share due to high disease prevalence and recognition of binge-eating as part of obesity management.
Adolescents represent a growing subsegment due to rising early-life obesity, depression, and anxiety. Early intervention is increasingly prioritized.
Patients with comorbidities-such as diabetes, PCOS, or mood disorders-represent a key clinical focus for integrated treatment.

By End User
Hospitals and psychiatric centers manage severe or complex BED cases requiring multidisciplinary care.
Specialized eating disorder clinics provide structured therapy programs and medical monitoring.
Outpatient mental health centers dominate routine psychotherapy and follow-up management.
Digital mental health platforms are emerging as a major access point for early-stage or mild-to-moderate BED.

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71896

Regional Insights
North America
North America leads the market due to high awareness, strong access to psychiatric care, widespread use of pharmacotherapy, and strong adoption of digital therapy platforms. The U.S. has the highest BED diagnosis and treatment rates globally.

Europe
Europe represents a significant market supported by strong mental health policies, early eating disorder detection programs, and widespread access to psychotherapy. Countries such as the UK, Germany, and the Netherlands show high treatment adoption.

Asia Pacific
Asia Pacific is the fastest-growing region, driven by rising stress levels, increased social pressures, urbanization, and growing awareness of mental health issues. Expanding tele-mental-health adoption in India, China, Japan, and Australia strengthens growth.

Latin America & Middle East/Africa
These regions show increasing recognition of eating disorders and improving access to behavioral therapies, though cultural stigma and limited specialist availability remain barriers.

Competitive Landscape

The BED market includes pharmaceutical companies, behavioral therapy providers, and digital mental health innovators.
Key Companies Include:
• Takeda
• Novo Nordisk
• Shire (now part of Takeda)
• Pfizer
• Eli Lilly
• Johnson & Johnson
• Alkermes
• Talkspace
• BetterHelp
• Noom

These organizations focus on expanding pharmacological treatment options, enhancing digital CBT delivery, and integrating metabolic and psychiatric care.

Recent Developments
• Increasing global uptake of lisdexamfetamine as the first FDA-approved medication for BED.
• Growth in AI-driven therapy platforms targeting eating behavior patterns.
• Expansion of cross-specialty programs combining obesity treatment with psychiatric care.
• Clinical research evaluating GLP-1 agonists for reducing binge frequency and food cravings.
• Increased corporate mental health programs offering BED support services.

This report is also available in the following languages : Japanese (過食症市場), Korean (폭식증 시장), Chinese (暴食症市场), French (Marché des troubles de l'hyperphagie boulimique), German (Markt für Essstörungen), and Italian (Mercato dei disturbi da alimentazione incontrollata), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71896

Our More Reports:

Lupus Nephritis Patient Pool Analysis Market
https://exactitudeconsultancy.com/reports/71619/lupus-nephritis-patient-pool-analysis-market

Metastatic Prostate Cancer Patient Pool Analysis Market
https://exactitudeconsultancy.com/reports/71621/metastatic-prostate-cancer-patient-pool-analysis-market

Myasthenia Gravis Patient Pool Analysis Market
https://exactitudeconsultancy.com/reports/71623/myasthenia-gravis-patient-pool-analysis-market

Peripheral T-Cell Lymphoma (PTCL) Patient Pool Analysis, Market
https://exactitudeconsultancy.com/reports/71625/peripheral-t-cell-lymphoma-ptcl-patient-pool-analysis-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.